State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Centre for Eye Research Australia; Ophthalmology, Department of Surgery, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Eye (Lond). 2020 Feb;34(2):383-391. doi: 10.1038/s41433-019-0550-8. Epub 2019 Aug 9.
To investigate if smoking was related to the risk of cataract surgery in diabetic patients.
A total of 9578 diabetic participants aged 45-65 years were enrolled from the 45 and Up Study, the largest population-based cohort study in Australia. Baseline questionnaire data were linked to the Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) database, which were both available from 2004 to 2016. Cataract surgery was determined according to the MBS. Smoking status were assessed by questionnaire. Cox regression was used to evaluate the association between smoking and incidence of cataract surgery during the follow-up.
During a mean follow-up of 8.4 years, 995 participants underwent cataract surgery with a corresponding incidence of 12.4 cases per 1000 person-years. In all, 10.8% of participants were current smokers at baseline, 38.7% were former smokers, and 50.5% were never smokers. The incidence of cataract surgery was non-significantly higher in never-smoker compared to former or current smokers. Regression analysis showed no significant difference in cataract surgical risk among former, current, and never smokers. In addition, neither time since quitting of smoking nor age at quitting was associated with the risk of cataract surgery, although there was a marginally significant trend in a lower risk of cataract surgery with longer smoking cessation time for participant with normal weight (P for trend = 0.05).
Despite that smoking was found to be related to the cataract and cataract surgery in the general population, we did not find any association between smoking and cataract surgery in diabetic patients.
探讨吸烟是否与糖尿病患者白内障手术风险相关。
共纳入来自澳大利亚最大的人群队列研究 45 and Up Study 的 9578 名 45-65 岁的糖尿病患者。基线问卷调查数据与 Medicare Benefits Schedule(MBS)和 Pharmaceutical Benefits Scheme(PBS)数据库相关联,这些数据库的信息可追溯到 2004 年至 2016 年。白内障手术的诊断依据 MBS 确定。吸烟状况通过问卷评估。Cox 回归用于评估随访期间吸烟与白内障手术发生率之间的关系。
在平均 8.4 年的随访期间,995 名参与者接受了白内障手术,相应的发生率为每 1000 人年 12.4 例。共有 10.8%的参与者在基线时为当前吸烟者,38.7%为曾经吸烟者,50.5%为从不吸烟者。从不吸烟者的白内障手术发生率与既往或当前吸烟者相比无显著差异。回归分析显示,既往、当前和从不吸烟者的白内障手术风险无显著差异。此外,戒烟时间或戒烟年龄与白内障手术风险均无显著相关性,尽管对于体重正常的参与者,较长的戒烟时间与白内障手术风险降低呈边缘显著趋势(趋势检验 P 值=0.05)。
尽管吸烟与一般人群的白内障和白内障手术有关,但我们未发现吸烟与糖尿病患者白内障手术之间存在关联。